Granahan Investment Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-602,153
| Closed | -$6.08M | – | 170 |
|
|
2022
Q4 | $6.08M | Buy |
602,153
+275,734
| +84% | +$2.78M | 0.19% | 119 |
|
|
2022
Q3 | $7.32M | Buy |
326,419
+63,263
| +24% | +$1.42M | 0.24% | 106 |
|
|
2022
Q2 | $6.52M | Buy |
263,156
+58,211
| +28% | +$1.44M | 0.22% | 102 |
|
|
2022
Q1 | $7.95M | Buy |
204,945
+71,544
| +54% | +$2.77M | 0.2% | 106 |
|
|
2021
Q4 | $7.81M | Buy |
133,401
+58,909
| +79% | +$3.45M | 0.16% | 129 |
|
|
2021
Q3 | $4.42M | Buy |
+74,492
| New | +$4.42M | 0.08% | 159 |
|